Prostate Cancer Clinical Trial
Improving Germline Testing in At-Risk Patients With Prostate Cancer
Summary
A quality improvement initiative to improve rates of germline testing among men with prostate cancer through the use of an in-clinic educational session.
Full Description
This is a prospective single arm quality improvement initiative for the use of a standardized educational intervention on germline testing in prostate cancer to improve the rates of germline genetic testing among patients recommended for testing. Patients who consent to the study will undergo a one-on-one education session regarding the rationale and the benefits/risks of germline testing. Following the educational session, if a patient wishes to proceed with testing, they will sign the standard consent to proceed with germline testing via a commercial assay.
Eligibility Criteria
Inclusion Criteria:
Men, age greater than or equal to 18 years of age.
Diagnosis of prostate cancer of any histology.
Must meet NCCN guidelines for germline testing
Exclusion Criteria:
Have had prior germline testing.
Have somatic genetic testing that is positive for a possible germline variant.
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
How clear is this clinincal trial information?
